Free Trial

Petros Pharmaceuticals (PTPI) SEC Filings & 10K Form

Petros Pharmaceuticals logo
$0.16 +0.02 (+15.70%)
Closing price 04:00 PM Eastern
Extended Trading
$0.15 -0.01 (-4.88%)
As of 04:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Petros Pharmaceuticals SEC Filings

DateFilerForm TypeView
02/17/2025
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
02/14/2025
7:55 PM
Petros Pharmaceuticals (Filer)
Form S-1MEF
02/14/2025
10:28 AM
Petros Pharmaceuticals (Filer)
Form S-1/A
02/13/2025
12:44 PM
Ayrton Capital LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/13/2025
8:42 AM
Petros Pharmaceuticals (Filer)
Form S-1/A
12/16/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/21/2024
3:57 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
3:21 PM
Petros Pharmaceuticals (Filer)
Form DEFA14A
11/13/2024
4:11 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/13/2024
10:14 AM
INTRACOASTAL CAPITAL, LLC (Filed by)
Petros Pharmaceuticals (Subject)
Form SC 13G/A
10/25/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form DEF 14A
10/25/2024
4:02 PM
Petros Pharmaceuticals (Filer)
Form ARS
10/18/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/17/2024
4:07 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/15/2024
4:19 PM
Petros Pharmaceuticals (Filer)
Form PRE 14A
10/04/2024
4:15 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/19/2024
3:05 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2024
11:15 PM
Petros Pharmaceuticals (Filer)
Form EFFECT
05/15/2024
4:00 PM
Petros Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/01/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/22/2024
3:31 PM
Petros Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PTPI) was last updated on 2/19/2025 by MarketBeat.com Staff
From Our Partners